Re: Secondary Medical Prevention in Patients with Peripheral Arterial Disease

European Journal of Vascular and Endovascular Surgery

Volumn 35, Issue 1, 2008, Pages 59-60

  Schouten, O ^a   Welten, G M J M ^a   Bax, J J ^b   Poldermans, D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIAZIDE DIURETIC AGENT;

ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DRUG ACTIVITY; DRUG EFFICACY; HEART INFARCTION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SECONDARY PREVENTION;

EID: 36849062636     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2007.07.006     Document Type: Note

References (3)

1. Steg P.G., Bhatt D.L., Wilson P.W., D'Agostino Sr. R., Ohman E.M., Rother J., et al. One-year cardiovascular event rates in outpatients with atherothrombosis. Jama 297 (2007) 1197-1206
2. Reference to the paper of Gasse et al. EJVES 4304.
3. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., et al. Inter-Society consensus for the management of peripheral arterial disease TASC II. Eur J Vasc Endovasc Surg 33 Suppl. 1 (2007) S1-S75